Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331
Titel:
Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331
Auteur:
Reck, M. Vicente, D. Ciuleanu, T. Gettinger, S. Peters, S. Horn, L. Audigier-Valette, C. Pardo, N. Juan-Vidal, O. Cheng, Y. Zhang, H. Shi, M. Wolf, J. Antonia, S.J. Nakagawa, K. Selvaggi, G. Baudelet, C. Chang, H. Spigel, D.R.